glucagon has been researched along with Mixed Tumor, Malignant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirano, H; Nakasho, K; Nishigami, T; Oyama, H; Terada, N; Yamada, N; Yamanegi, Y | 1 |
| Alatsakis, MB; Ballas, KD; Demertzidis, C; Pantzaki, A; Rafailidis, SF; Sakadamis, AK | 1 |
2 other study(ies) available for glucagon and Mixed Tumor, Malignant
| Article | Year |
|---|---|
A case of mixed ductal-endocrine carcinoma of the pancreas.
Topics: Adenocarcinoma; Aged; Ampulla of Vater; Amylases; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Chromogranin A; Endocrine Gland Neoplasms; Fatal Outcome; Female; Glucagon; Humans; Keratin-19; Keratin-20; Ki-67 Antigen; Male; Middle Aged; Mixed Tumor, Malignant; Pancreatic Neoplasms | 2011 |
Mixed exocrine-endocrine tumor of the pancreas.
Topics: Aged; Carcinoma, Islet Cell; Carcinoma, Pancreatic Ductal; Chromogranins; Female; Gastrins; Glucagon; Humans; Immunohistochemistry; Mixed Tumor, Malignant; Pancreatic Neoplasms; Phosphopyruvate Hydratase; Somatostatin | 2005 |